Most bought healthcare stocks in Q4 2021
See which Healthcare stocks institutional investors increased the most in Q4 2021, measured as net growth in reported share positions from Q3 2021 into Q4 2021. Notable additions at the top of this list include ELANCO ANIMAL HEALTH INC (ELAN), BOSTON SCIENTIFIC CORP (BSX), WEAVE COMMUNICATIONS INC (WEAV), TILRAY BRANDS INC (TLRY). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| ELAN | ELANCO ANIMAL HEALTH INC | 19,056,665 | $515.91K | 0 | 3 | 1 | 0 | 4 |
| BSX | BOSTON SCIENTIFIC CORP | 12,067,173 | $492.08K | 0 | 1 | 2 | 0 | 4 |
| WEAV | WEAVE COMMUNICATIONS INC | 7,426,846 | $112.74K | 1 | 0 | 0 | 0 | 1 |
| TLRY | TILRAY BRANDS INC | 5,211,591 | $36.65K | 1 | 0 | 0 | 0 | 1 |
| OSCR | OSCAR HEALTH INC - CLASS A | 4,802,823 | -$35.61K | 2 | 1 | 1 | 0 | 4 |
| VTYX | VENTYX BIOSCIENCES INC | 4,312,834 | $83.08K | 1 | 0 | 0 | 0 | 1 |
| TDOC | TELADOC HEALTH INC | 3,779,959 | -$229.27K | 1 | 1 | 1 | 0 | 3 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 3,386,228 | -$47.77K | 0 | 1 | 0 | 1 | 1 |
| GILD | GILEAD SCIENCES INC | 3,246,032 | $391.90K | 0 | 3 | 5 | 0 | 8 |
| FMS | FRESENIUS MEDICAL CARE-ADR | 3,227,895 | $86.56K | 0 | 2 | 0 | 0 | 2 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 3,182,893 | $479.20K | 1 | 3 | 1 | 0 | 5 |
| ISRG | INTUITIVE SURGICAL INC | 2,621,562 | $109.51K | 0 | 6 | 0 | 1 | 6 |
| ARDX | ARDELYX INC | 2,040,421 | $2.24K | 1 | 0 | 0 | 0 | 1 |
| ABT | ABBOTT LABORATORIES | 1,888,518 | $1.01M | 0 | 3 | 3 | 0 | 8 |
| EXAS | EXACT SCIENCES CORP | 1,767,385 | -$69.10K | 0 | 1 | 0 | 0 | 1 |
| AVTR | AVANTOR INC | 1,687,592 | $100.63K | 0 | 2 | 0 | 0 | 3 |
| SGRY | SURGERY PARTNERS INC | 1,606,631 | $85.95K | 1 | 1 | 0 | 0 | 2 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,473,331 | $46.56K | 0 | 2 | 0 | 0 | 2 |
| VCYT | VERACYTE INC | 1,242,080 | $14.53K | 0 | 1 | 0 | 0 | 1 |
| XRAY | DENTSPLY SIRONA INC | 1,200,374 | $48.79K | 0 | 2 | 1 | 0 | 3 |
| ATOS | ATOSSA THERAPEUTICS INC | 1,170,340 | $1.87K | 1 | 0 | 0 | 0 | 1 |
| OGN | ORGANON & CO | 1,149,952 | -$175.81K | 1 | 2 | 2 | 1 | 5 |
| BEAM | BEAM THERAPEUTICS INC | 1,141,679 | $40.90K | 0 | 1 | 0 | 0 | 1 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 1,031,589 | $3.02K | 2 | 0 | 0 | 0 | 2 |
| HYPR | HYPERFINE INC | 1,000,000 | $7.25K | 1 | 0 | 0 | 0 | 1 |
| MPLN | MULTIPLAN CORP | 984,892 | $4.34K | 0 | 1 | 0 | 0 | 1 |
| AMGN | AMGEN INC | 981,903 | $230.25K | 0 | 5 | 2 | 0 | 7 |
| BIIB | BIOGEN INC | 949,525 | $164.80K | 1 | 1 | 1 | 0 | 5 |
| EHC | ENCOMPASS HEALTH CORP | 860,390 | $54.39K | 1 | 2 | 0 | 0 | 3 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 841,447 | -$183.05K | 0 | 1 | 0 | 0 | 2 |
| MCRB | SERES THERAPEUTICS INC | 746,500 | $6.22K | 1 | 0 | 0 | 0 | 1 |
| HOLX | HOLOGIC INC | 745,886 | -$68.74K | 0 | 3 | 1 | 0 | 4 |
| AIM | AIM IMMUNOTECH INC | 705,100 | $649 | 1 | 0 | 0 | 0 | 1 |
| SDGR | SCHRODINGER INC | 654,146 | -$161.14K | 0 | 1 | 0 | 0 | 2 |
| CTLT | CATALENT INC | 514,391 | $52.37K | 0 | 1 | 3 | 0 | 4 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 513,100 | $34.88K | 0 | 2 | 0 | 0 | 2 |
| BDX | BECTON DICKINSON AND CO | 492,335 | $81.40K | 0 | 5 | 5 | 1 | 11 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 469,700 | $2.38K | 0 | 1 | 0 | 0 | 1 |
| AUPH | AURINIA PHARMACEUTICALS INC | 467,071 | $10.68K | 1 | 0 | 0 | 0 | 1 |
| ABCL | ABCELLERA BIOLOGICS INC | 454,903 | $6.02K | 0 | 1 | 0 | 0 | 1 |
| CAH | CARDINAL HEALTH INC | 432,350 | $30.49K | 1 | 2 | 1 | 0 | 4 |
| CRVS | CORVUS PHARMACEUTICALS INC | 429,362 | -$459 | 0 | 1 | 0 | 0 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | 427,687 | $1.60K | 1 | 0 | 0 | 0 | 1 |
| BFLY | BUTTERFLY NETWORK INC | 425,698 | -$24.12K | 0 | 1 | 0 | 0 | 1 |
| DOCS | DOXIMITY INC-CLASS A | 414,987 | -$25.05K | 1 | 1 | 0 | 0 | 3 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 385,400 | $2.05K | 1 | 0 | 0 | 0 | 1 |
| GDRX | GOODRX HOLDINGS INC-CLASS A | 376,855 | -$7.24K | 2 | 0 | 0 | 0 | 3 |
| CPRX | CATALYST PHARMACEUTICALS INC | 370,648 | $2.59K | 0 | 1 | 0 | 0 | 1 |
| QSI | QUANTUM-SI INC | 368,769 | -$3.07K | 0 | 1 | 0 | 0 | 1 |
| SYK | STRYKER CORP | 355,325 | $129.69K | 1 | 4 | 0 | 0 | 6 |
Frequently asked questions about Most bought healthcare stocks in Q4 2021
What are the most bought Healthcare stocks in Q4 2021?
The most bought healthcare stocks in Q4 2021 are those with the largest increase in reported share counts across tracked institutional investors compared to Q3 2021, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q4 2021?
Among the managers we track, net additions were largest in companies such as ELANCO ANIMAL HEALTH INC (ELAN), BOSTON SCIENTIFIC CORP (BSX), WEAVE COMMUNICATIONS INC (WEAV), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q3 2021).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.